Table 3 Adverse events reported in each group
Placebo (%) | MPD (%) | Total | |
|---|---|---|---|
Insomnia, Anxiety/Nervousness | 2 (16,67) | 11 (37,93) | 13 |
Headache | 3 (25,00) | 3 (10,34) | 6 |
Anorexia/Decreased appetite | 0 (0,00) | 6 (20,69) | 6 |
Abdominal pain | 2 (16,67) | 2 (6,90) | 4 |
Abnormal loss of weight | 1 (8,33) | 1 (3,45) | 2 |
Vomiting/Nausea | 0 (0,00) | 2 (6,90) | 2 |
Other* | 4 (33,33) | 4 (13,79) | 8 |
Total | 12 | 29 | 41 |